Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Starboard's Kenvue complaints are much different than those aimed at Pfizer
7 months ago
Lawyers predict Biosecure passage in lame duck session, but Senate may decide key details
7 months ago
China
FDA+
ICER slightly softens its recommendation on Pfizer's ATTR-CM drug price
7 months ago
FDA+
Updated: Pfizer's activist says board must 'hold management accountable' for R&D shortcomings
7 months ago
Biden administration calls for expanded contraception coverage
7 months ago
FDA+
Lilly files more lawsuits over sales of copycat Zepbound
7 months ago
Law
Starboard takes activist stake in J&J consumer spinout Kenvue
7 months ago
FDA to launch pilot project for more transparency on generic drug delays
7 months ago
FDA+
AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity
7 months ago
Manufacturing
Catalent moves to reassure customers about what happens after merger
7 months ago
Manufacturing
NJ judge tosses Novartis' IRA lawsuit in another win for government
7 months ago
Law
Lykos is optimistic about MDMA treatment after meeting with FDA
7 months ago
R&D
FDA+
FDA approves Astellas' gastric cancer drug Vyloy ahead of schedule
7 months ago
FDA+
EMA again recommends against authorization for PTC Therapeutics' Translarna
7 months ago
FDA+
FDA partially holds BioNTech's Phase 3 anti-CTLA-4, company pauses enrollment
7 months ago
R&D
FDA+
Gilead pulls Trodelvy's accelerated label in bladder cancer after drug failed confirmatory study
7 months ago
R&D
Consumer and union groups call on FTC to ‘challenge’ Novo-Catalent deal
7 months ago
Deals
Manufacturing
Pfizer ends trial of Array-acquired SHP2 inhibitor after similar cuts from peers
7 months ago
R&D
Merck unveils RSV antibody data, in bid to compete with AstraZeneca and Sanofi
7 months ago
R&D
Pfizer’s RSV vaccine has 90% efficacy against severe respiratory disease
7 months ago
Amicus stock jumps after resolution of Galafold patent litigation against Teva
7 months ago
Law
Intercept's liver disease drug faces full approval delay following negative adcomm
7 months ago
FDA+
FDA delays colorectal cancer decision for Amgen's Lumakras, a setback in race with Bristol Myers
7 months ago
FDA+
FDA expands label for Avadel's narcolepsy drug into children
7 months ago
FDA+
First page
Previous page
30
31
32
33
34
35
36
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit